ExodusPoint Capital Management, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$887
-78.7%
10,423
-79.3%
0.01%
-79.4%
Q1 2023$4,157
+39.4%
50,232
+32.5%
0.03%
-20.9%
Q4 2022$2,981
-99.0%
37,900
+561.9%
0.04%
+1333.3%
Q4 2021$304,000
-54.5%
5,726
-4.8%
0.00%
-70.0%
Q1 2021$668,000
-85.4%
6,015
-84.4%
0.01%
-77.8%
Q4 2020$4,570,000
-27.9%
38,488
-47.0%
0.04%
-64.6%
Q3 2020$6,339,000
+84.3%
72,659
+89.2%
0.13%
+42.7%
Q2 2020$3,439,000
-10.5%
38,401
+14.8%
0.09%
+23.6%
Q4 2019$3,842,00033,4370.07%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders